Back to search
Primary Inherited Erythromelalgia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Inherited Erythromelalgia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Inherited Erythromelalgia trials you may qualify forThe purpose of this study is to test the potential benefits of BHV-7000 in reducing chronic pain in participants with IEM with a previously demonstrated gain of…
The purpose of this study is to evaluate the efficacy and safety of single doses of PF-05089771 against placebo in treatment of pain in patients with primary, i…
The primary objective of the study is to investigate the efficacy of repeat oral dosing of BIIB074 on paroxysmal pain in participants with Primary Inherited Ery…
This is a Phase 2a single-center, randomized, double-blind, Placebo-controlled, parallel group study with XPF-002 applied twice daily over 14 or 21 days in pati…
The purpose of this study is to determine whether XPF-001 is safe and effective in the treatment of pain caused by Inherited Erythromelalgia (IEM).